Literature DB >> 18446371

Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.

Yan-Lin Tao1, Xun-Jia Cheng, Yong-Feng Fu, Hideo Tsukamoto, Eisaku Yoshihara, Hiroshi Tachibana.   

Abstract

We recently produced human monoclonal antibody Fab fragments specific for the 19-kDa C-terminal merozoite surface protein 1 of Plasmodium falciparum in a bacterial expression system. The effect of single amino acid modifications in the third complementarity-determining regions of the heavy and light chains on affinity was examined in one of the Fab fragments, Pf25. Recombination polymerase chain reaction was used to modify Tyr(92) or Ile(97) in the light chain and Val(101) or Trp(107) in the heavy chain. No effective replacements for Tyr(92) and Val(101) were found, but possible substitutions of Ile(97) with Gly, Leu, Glu, Ala and Ser, and of Trp(107) with Arg and Ser were demonstrated. Of these modified Fab fragments, the affinities of Fabs with Ile(97)-Leu and Trp(107)-Ser mutations were slightly higher than that of the original Fab. The effects of these modifications on the antigen-antibody interaction are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446371     DOI: 10.1007/s00436-008-0994-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

1.  Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody.

Authors:  K Winkler; A Kramer; G Küttner; M Seifert; C Scholz; H Wessner; J Schneider-Mergener; W Höhne
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

2.  Recombination and site-directed mutagenesis using recombination PCR.

Authors:  D H Jones; S C Winistorfer
Journal:  Methods Mol Biol       Date:  1997

3.  Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies.

Authors:  D Harning; J Spenter; A Metsis; J Vuust; E Petersen
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

5.  Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.

Authors:  J C Pizarro; V Chitarra; D Verger; I Holm; S Pêtres; S Dartevelle; F Nato; S Longacre; G A Bentley
Journal:  J Mol Biol       Date:  2003-05-16       Impact factor: 5.469

6.  Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.

Authors:  Xun-Jia Cheng; Hitoshi Hayasaka; Katsuomi Watanabe; Yan-Lin Tao; Jin-Ye Liu; Hideo Tsukamoto; Toshihiro Horii; Kazuyuki Tanabe; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

7.  Evaluation of recombinant fragments of Entamoeba histolytica Gal/GalNAc lectin intermediate subunit for serodiagnosis of amebiasis.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Gohta Masuda; Noriyuki Horiki; Tsutomu Takeuchi
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Inhibitory and neutral antibodies to Plasmodium falciparum MSP119 form ring structures with their antigen.

Authors:  Carien Dekker; Chairat Uthaipibull; Lesley J Calder; Matthew Lock; Munira Grainger; William D Morgan; Guy G Dodson; Anthony A Holder
Journal:  Mol Biochem Parasitol       Date:  2004-09       Impact factor: 1.759

10.  Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

Authors:  C Uthaipibull; B Aufiero; S E Syed; B Hansen; J A Guevara Patiño; E Angov; I T Ling; K Fegeding; W D Morgan; C Ockenhouse; B Birdsall; J Feeney; J A Lyon; A A Holder
Journal:  J Mol Biol       Date:  2001-04-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.